ConductScience.org, home

Paper37745839

Role of immunotherapy in chondrosarcoma: A case report and review of the literature.

Cohen-Nowak AJ and 7 others. Ther Adv Med Oncol, 2023. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Role of immunotherapy in chondrosarcoma: A case report and review of the literature. Papers, record 37745839. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37745839

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of immunotherapy in chondrosarcoma: A case report and review of the literature.
PubMed
Journal
Ther Adv Med Oncol
PubMed
Year
2023
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.5
iCite
Revised in PubMed
2023-09-26
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cohen-Nowak AJAdam Jhttps://orcid.org/0000-0001-6784-7159
2Dressler DBDanielle B
3Rock AAdam
4Mojica KKatherine
5Woo DDoni
6Zuckerman LMLee Mhttps://orcid.org/0000-0001-7762-2906
7Chow WWarrenhttps://orcid.org/0000-0003-0889-5841
8Agulnik MMark

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128241093Phase 1/2 study of immunotherapy with dendritic cells pulsed with autologous tumor lysate in patients with refractory bone and soft tissue sarcoma.Cancer2017https://conductscience.org/library/papers/28241093PubMed
232344648Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in Chondrosarcoma.Cells2020https://conductscience.org/library/papers/32344648PubMed
333203665Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial.J Immunother Cancer2020https://conductscience.org/library/papers/33203665PubMed
431956474The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target.J Bone Oncol2020https://conductscience.org/library/papers/31956474PubMed
531498474Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis.J Orthop Res2020https://conductscience.org/library/papers/31498474PubMed
628878676PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome.Front Pharmacol2017https://conductscience.org/library/papers/28878676PubMed
732612154The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.Cell Mol Immunol2020https://conductscience.org/library/papers/32612154PubMed
830253794Response to PD1 inhibition in conventional chondrosarcoma.J Immunother Cancer2018https://conductscience.org/library/papers/30253794PubMed
929862874Expression of PD-L1/PD-L2 is associated with high proliferation index of Ki-67 but not with TP53 overexpression in chondrosarcoma.Int J Biol Markers2018https://conductscience.org/library/papers/29862874PubMed
1032910151Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical Trial.JAMA Oncol2020https://conductscience.org/library/papers/32910151PubMed
1130519452Chondrosarcoma: biology, genetics, and epigenetics.F1000Res2018https://conductscience.org/library/papers/30519452PubMed
1231578273Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence.Oncologist2020https://conductscience.org/library/papers/31578273PubMed
1317545802Update on chondrosarcomas.Curr Opin Oncol2007https://conductscience.org/library/papers/17545802PubMed
1428688724PD-1 and PD-L1 expression in bone and soft tissue sarcomas.Pathology2017https://conductscience.org/library/papers/28688724PubMed
1531629410Tumor-associated macrophages: an accomplice in solid tumor progression.J Biomed Sci2019https://conductscience.org/library/papers/31629410PubMed
1636110930Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy.Front Oncol2022https://conductscience.org/library/papers/36110930PubMed
1727696380Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.Cancer2017https://conductscience.org/library/papers/27696380PubMed
1825949923The combination of a novel immunomodulator with a regulatory T cell suppressing antibody (DTA-1) regress advanced stage B16F10 solid tumor by repolarizing tumor associated macrophages in situ.Oncoimmunology2015https://conductscience.org/library/papers/25949923PubMed
1924897071Vascular pattern in enchondroma and chondrosarcoma: clinical and immunohistologic study.Appl Immunohistochem Mol Morphol2014https://conductscience.org/library/papers/24897071PubMed
208608988Prognostic significance of Ki67 (MIB1) proliferation index and p53 over-expression in chondrosarcomas.Int J Cancer1996https://conductscience.org/library/papers/8608988PubMed

See all 51 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
41752158Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma.Int J Mol Sci2026https://conductscience.org/library/papers/41752158PubMed
41609192
A Case Report of Promising Response to Combination Therapy With an Immune Checkpoint Inhibitor (Pembrolizumab) and Multi-Targeted Tyrosine Kinase Inhibitor (Pazopanib) in Metastatic De-Differentiated Chondrosarcoma.
Cancer Rep (Hoboken)2026https://conductscience.org/library/papers/41609192PubMed
41079102Andrographolide suppresses chondrosarcoma cell migration and invasion by inhibiting the PI3K/Akt/mTOR signaling pathway and activating autophagy.Front Oncol2025https://conductscience.org/library/papers/41079102PubMed
40927310Immunotherapy and Targeted Therapies in Sarcoma: Proposed Synergy with Combination Treatment.J Immunother Precis Oncol2025https://conductscience.org/library/papers/40927310PubMed
40117529Genomic Characterization of Chondrosarcoma Reveals Potential Therapeutic Targets.JCO Precis Oncol2025https://conductscience.org/library/papers/40117529PubMed
40004005Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches.Int J Mol Sci2025https://conductscience.org/library/papers/40004005PubMed
39652252Advancing Systemic Therapy in Chondrosarcoma: New Horizons.Oncol Ther2025https://conductscience.org/library/papers/39652252PubMed
39590345Genetics and Molecular Pathogenesis of the Chondrosarcoma: A Review of the Literature.Curr Issues Mol Biol2024https://conductscience.org/library/papers/39590345PubMed
39540661Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial.Cancer2025https://conductscience.org/library/papers/39540661PubMed
39276177Comparisons of clinical characteristics, treatments, and outcomes among different pathological subtypes of chondrosarcoma in the spine.J Neurooncol2024https://conductscience.org/library/papers/39276177PubMed
39156101Global research development of chondrosarcoma from 2003 to 2022: a bibliometric analysis.Front Pharmacol2024https://conductscience.org/library/papers/39156101PubMed

Download CSV of cited by

Genes20

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
CD1639332PubTator's text mininghttps://conductscience.org/library/genes/9332NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD27680381PubTator's text mininghttps://conductscience.org/library/genes/80381NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CS1431PubTator's text mininghttps://conductscience.org/library/genes/1431NCBI Gene
CSPG41464PubTator's text mininghttps://conductscience.org/library/genes/1464NCBI Gene
IDH13417PubTator's text mininghttps://conductscience.org/library/genes/3417NCBI Gene
IDH23418PubTator's text mininghttps://conductscience.org/library/genes/3418NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL12B3593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
NR1I39970PubTator's text mininghttps://conductscience.org/library/genes/9970NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37745839

GET https://conductscience.org/api/papers/v1/37745839/references?page=2